Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
dc.contributor.author | Karasu Z. | |
dc.contributor.author | Yilmaz F. | |
dc.contributor.author | Ersöz G. | |
dc.contributor.author | Günşar F. | |
dc.contributor.author | Batur Y. | |
dc.contributor.author | Akarca U.S. | |
dc.date.accessioned | 2019-10-27T00:25:15Z | |
dc.date.available | 2019-10-27T00:25:15Z | |
dc.date.issued | 2001 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Background/aims: There are several parameters which may predict the response to interferon therapy in patients with chronic hepatitis B and chronic hepatitis C. The aim of this study was to evaluate the predictive value of proliferating cell nuclear antigen index (PCAN-i) in determining the response rate to interferon therapy in patients with these infections. Methods: Twenty-three patients with chronic hepatitis B and 27 with chronic hepatitis C were included in the study. Prior to therapy, liver biopsies were evaluated with respect to Knodell's index and PCNA-i. Results: Histologic activity indices of the patients with chronic hepatitis B and chronic hepatitis C were similar, but the patients with chronic hepatitis B had higher PCNA-i compared to those with chronic hepatitis C (15.4±5.5 vs 11.3±5.0, p=0.009). PCNA-i was significantly lower in non-responders than responders in the chronic hepatitis B group, whereas responders tended to have lower PCNA-i values in patients with chronic hepatitis C. Conclusions: Responders with chronic hepatitis B had elevated PCNA-i, while the patients with chronic hepatitis C who responded to interferon therapy tended to have lower PCNA-i but the reason for that difference is not clear. According to these results PCNA-i may be used as a predictive marker for the response to interferon therapy in patients with chronic hepatitis B. | en_US |
dc.identifier.endpage | 94 | en_US |
dc.identifier.issn | 1300-4948 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 89 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/23219 | |
dc.identifier.volume | 12 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Turkish Journal of Gastroenterology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Chronic hepatitis B | en_US |
dc.subject | Chronic hepatitis C | en_US |
dc.subject | Interferon | en_US |
dc.subject | PCNA | en_US |
dc.title | Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C | en_US |
dc.type | Article | en_US |